We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $46.3B
1-Year Est. Return 43.9%
This Fund
S&P 500
This Quarter Est. Return
-13.93%
1 Year Est. Return
+43.9%
3 Year Est. Return
+135.96%
5 Year Est. Return
+174.68%
10 Year Est. Return
+648.16%
AUM
$20B
AUM Growth
-$5.25B
Cap. Flow
-$1.13B
Cap. Flow %
-5.62%
Top 10 Hldgs %
21.83%
Holding
1,650
New
389
Increased
426
Reduced
533
Closed
104

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$109M
2
ABBV icon
AbbVie
ABBV
+$68.7M
3
ORCL icon
Oracle
ORCL
+$63.5M
4
KO icon
Coca-Cola
KO
+$54.4M
5
ABT icon
Abbott
ABT
+$52.2M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$112M
2
AAPL icon
Apple
AAPL
+$97.1M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$87.3M
4
NVDA icon
NVIDIA
NVDA
+$66.6M
5
MSFT icon
Microsoft
MSFT
+$63M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Healthcare 21.45%
3 Financials 13.18%
4 Consumer Discretionary 9.11%
5 Consumer Staples 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WH icon
876
Wyndham Hotels & Resorts
WH
$5.58B
$271K ﹤0.01%
4,125
MLI icon
877
Mueller Industries
MLI
$15.4B
$269K ﹤0.01%
+20,164
New +$273K
UCB
878
United Community Banks
UCB
$4.28B
$269K ﹤0.01%
+8,922
New +$274K
IIPR icon
879
Innovative Industrial Properties
IIPR
$1.69B
$266K ﹤0.01%
2,419
-821
-25% -$116K
SIG icon
880
Signet Jewelers
SIG
$3.65B
$266K ﹤0.01%
4,977
FORM icon
881
FormFactor
FORM
$9B
$265K ﹤0.01%
+6,851
New +$264K
VIAV icon
882
Viavi Solutions
VIAV
$10B
$264K ﹤0.01%
19,970
+14,087
+239% +$203K
AEL
883
DELISTED
American Equity Investment Life Holding Company
AEL
$264K ﹤0.01%
+7,230
New +$275K
CNMD icon
884
CONMED
CNMD
$1.49B
$261K ﹤0.01%
2,726
-1,417
-34% -$170K
GPI icon
885
Group 1 Automotive
GPI
$3.23B
$261K ﹤0.01%
1,536
-94
-6% -$16.4K
BKU icon
886
Bankunited
BKU
$3.37B
$260K ﹤0.01%
+7,321
New +$290K
TPR icon
887
Tapestry
TPR
$32.7B
$260K ﹤0.01%
8,515
HI
888
DELISTED
Hillenbrand
HI
$257K ﹤0.01%
6,266
+3,321
+113% +$139K
SANM icon
889
Sanmina
SANM
$11B
$257K ﹤0.01%
6,319
-953
-13% -$39.4K
ATI icon
890
ATI
ATI
$30.5B
$256K ﹤0.01%
+11,265
New +$297K
CYTK icon
891
Cytokinetics
CYTK
$11B
$255K ﹤0.01%
6,479
+3,794
+141% +$153K
FBP icon
892
First Bancorp
FBP
$4.44B
$254K ﹤0.01%
19,705
-4,848
-20% -$66.3K
HTHT icon
893
Huazhu Hotels Group
HTHT
$13.2B
$252K ﹤0.01%
6,622
ABM icon
894
ABM Industries
ABM
$2.84B
$251K ﹤0.01%
5,777
+3,447
+148% +$159K
NTCT icon
895
NETSCOUT
NTCT
$2.92B
$250K ﹤0.01%
7,399
-4,736
-39% -$159K
ETRN
896
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$250K ﹤0.01%
39,257
TWNK
897
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$249K ﹤0.01%
+11,751
New +$254K
COKE icon
898
Coca-Cola Consolidated
COKE
$12.5B
$248K ﹤0.01%
4,390
-950
-18% -$49.6K
LZB icon
899
La-Z-Boy
LZB
$1.63B
$247K ﹤0.01%
10,404
+3,816
+58% +$98.2K
PBF icon
900
PBF Energy
PBF
$7.26B
$246K ﹤0.01%
+8,492
New +$266K

Similar funds

KBC Group's Q2 2022 Portfolio in Review

As of Q2 2022, KBC Group held 1,650 positions worth $20B, down 21% from $25.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

KBC Group withdrew a net $1.13B in Q2 2022, closing 104 positions and reducing 533 holdings. Its most notable exit was Cerner Corp, an estimated $17.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.

Against the trend, KBC Group opened a new position in AstraZeneca worth $1.34M.

  • KBC Group's largest Q2 2022 buy was AstraZeneca: 10,181 shares worth $1.34M.
  • KBC Group added most to Merck in Q2 2022, an estimated $109M increase.
  • KBC Group's biggest Q2 2022 reduction was Amazon, cutting an estimated $112M.
  • KBC Group fully exited Cerner Corp in Q2 2022, selling an estimated $17.5M.
  • KBC Group's ten largest holdings make up 22% of its $20B portfolio in Q2 2022.
  • KBC Group opened 389 new positions and closed 104 in Q2 2022.
  • KBC Group's portfolio value fell 21% quarter-over-quarter to $20B.

Based on KBC Group's 13F filing for Q2 2022, filed 26 Jul 2022.